Manon Boisclair MS, MBA, ICD.D

Manon Boisclair MS, MBA, ICD.D has an extensive work experience. Starting in 2022, they have been the Chief Strategy & Growth Officer, Co-President at AquaAction. From 2021 to 2021, they were the Limited Partner & Investment Committee Advisor at Accelia Capital and the Lead Director at Gray Oncology Solutions. In 2020, they were a Guest Panelist at McGill University - Desautels Faculty of Management and a Board of Directors at Ovensa Inc. In 2021, they were a Board of Directors (Independent Observer) at Nursesimple and a Chief Commercial Officer (Strategic Consultant) at Syantra Inc. From 2019 to 2021, they were the CEO & Founder (Strategic Impact Consulting) at InnovID B2, a Board of Directors at MedHelper, and an Angel Investor & Advisor in Life Science at Anges Qu\u00e9bec.

Manon Boisclair holds an MSc in Nursing from McGill University and University of Montreal, an Executive MBA in Leadership & Management from McGill University's Desautels Faculty of Management, a Venture Capital, Distressed Investing & Restructuring (Business l Finance) from The Wharton School, and Corporate Director Certificates from Harvard Business School, MIT Sloan School of Management, and University of Toronto's Rotman School of Management. Boisclair also holds additional certifications, including an ESG Competent Boards- Certification & Designation (Candidate) from Competent Boards, an ESG Investing Certificate (Candidate) from CFA Institute, a Governance- Corporate Director Certificate from Institute of Corporate Directors, an Accelerating Innovation in Precision Medicine from Harvard Business School, a Leading Digital Transformation in Healthcare from Harvard Medical School, and a Lean Six Sigma, Yellow Belt Certification from McGill University.